VITA Magazine » COMMUNITAS » Yalla Italia! » SUBSCRIBE TO OUR NEWSLETTER »

Tag UNAIDS

Divided Opinions on Feasibility of Kenya’s Option B+ Roll Out

Nairobi – Kenya’s health sector has been facing significant challenges, ranging from a shortage of health care providers to a series of labour strikes. The problems have not only disrupted health services, but have HIV experts divided on whether to roll out Option B+ nationwide or just to pilot it in high volume facilities such as major referral hospitals.

continue reading »

Breast Is Best, But Not in Swaziland

Mbabane – Smiling as she breastfeeds her six-week-old baby boy, Lindiwe Dlamini, 38, is optimistic about his future. Dlamini, who is HIV-positive, is determined that her baby will not be infected. The mother of three – who conceived her first two children when she was HIV-negative – was on antiretroviral therapy (ART) when she delivered a healthy boy in November.

continue reading »

Pros and Cons of Uganda’s New ARV Therapy for Pregnant Women

Kampala – Uganda has gotten plenty of kudos and some criticism over its roll out of the new antiretroviral therapy for pregnant women and their babies, known as Option B +.

continue reading »

Africa: Unaids Upbeat About Aids Retreat

The AIDS epidemic is in decline and if countries “invest smartly” in a few key interventions, they can achieve “substantial and sustainable progress” against HIV. This is the upbeat message from UNAIDS, at the launch of its annual world report on the state of the epidemic.

continue reading »

HIV/AIDS: Rethinking contraception and infection risk

Hormonal birth-control injections may double a woman’s risk of contracting HIV and passing it on to her partner, according to a new study. The research comes at a time when many governments are looking to scale up their family-planning programmes in a bid to reduce maternal mortality.

continue reading »

HIV: ARVs as prevention must move quickly

NAIROBI – A landmark study showing major reductions in HIV transmission among discordant couples due to early treatment may fail to have a significant impact on HIV prevention unless governments and donors are willing to turn the science into action, HIV advocates say.

continue reading »

Project by VITA SOCIETÀ EDITORIALE S.P.A.
P.IVA 11273390150
ISCRIZIONE ROC N.3275
Direttore Responsabile afronline.org: Giuseppe Frangi
©2011-2015